ОЦЕНКА СЕРДЕЧНО – СОСУДИСТОГО РИСКА ПОСЛЕ МЕТАБОЛИЧЕСКОЙ И БАРИАТРИЧЕСКОЙ ХИРУРГИИ ПРИ МОРБИДНОМ ОЖИРЕНИИ
Ключевые слова:
сердечно-сосудистые риски; метаболическая и бариатрическая хирургия; сокращение рисков; снижение сердечно-сосудистого риска; лапароскопическая вертикальная гастрэктомия (ЛВГЭ)Аннотация
Сердечно - сосудистые заболевания (ССЗ) являются ведущей причиной смертности в мире, а ожирение является общепризнанным фактором риска сердечно-сосудистых заболеваний. Раннее выявление и лечение сердечно-сосудистых заболеваний имеет решающее значение для снижения риска сердечно-сосудистых заболеваний. Особенно у пациентов, страдающих ожирением, с факторами риска сердечно-сосудистых заболеваний, связанными с ожирением, такими как артериальная гипертензия (АГ), дислипидемия и сахарный диабет (СД). Существенное и устойчивое снижение массы тела после метаболической и бариатрической хирургии связано со значительным снижением сердечно-сосудистых факторов риска. В этой статье рассматриваются модели риска сердечно-сосудистых заболеваний, механизмы риска сердечно-сосудистых заболеваний, связанные с ожирением, и общее снижение риска сердечно-сосудистых заболеваний между различными метаболическими и бариатрическими процедурами.
Библиографические ссылки
Ожирение и избыточный вес Всемирной организации здравоохранения. [(по состоянию на 10 марта 2019 г.)]; 2018 г.
Adams TD, Davidson LE, Litwin SE, et al. Weight and Metabolic Outcomes 12 Years after Gastric Bypass. N Engl J Med 2017;377:1143-55.
Arterburn D, Schauer DP, Wise RE, et al. Change in predicted 10-year cardiovascular risk following laparoscopic Roux-en-Y gastric bypass surgery. Obes Surg 2009;19:184-9.
Askarpour M, Khani D, Sheikhi A, et al. Effect of Bariatric Surgery on Serum Inflammatory Factors of Obese Patients: a Systematic Review and Meta-Analysis. Obes Surg 2019;29:2631- 47.
Available online: https://www.who.int/en/news-room/fact-sheets/detail/cardiovascular- diseases-(cvds). Website accessed 1 Sept 2019.
Batra A, Siegmund B. The role of visceral fat. Dig Dis 2012;30:70-4.
Batsis JA, Sarr MG, Collazo-Clavell ML, et al. Cardiovascular risk after bariatric surgery for obesity. Am J Cardiol 2008;102:930-7.
Benotti PN, Wood GC, Carey DJ, et al. Gastric Bypass Surgery Produces a Durable Reduction in Cardiovascular Disease Risk Factors and Reduces the Long-Term Risks of Congestive Heart Failure. J Am Heart Assoc 2017.
Blanco DG, Funes DR, Giambartolomei G, et al. Laparoscopic sleeve gastrectomy versus Roux-en-Y gastric bypass in cardiovascular risk reduction: A match control study. Surg Obes Relat Dis 2019;15:14-20.
Cuspidi C, Rescaldani M, Tadic M, et al. Effects of bariatric surgery on cardiac structure and function: a systematic review and meta-analysis. Am J Hypertens 2014;27:146-56.
Després JP. Body fat distribution and risk of cardiovascular disease: an update. Circulation 2012;126:1301-13.
Eliasson B, Liakopoulos V, Franzén S, et al. Cardiovascular disease and mortality in patients with type 2 diabetes after bariatric surgery in Sweden: a nationwide, matched, observational cohort study. Lancet Diabetes Endocrinol 2015;3:847-54.
Gebhart A, Young M, Villamere J, et al. Changes in high-sensitivity C-reactive protein levels after laparoscopic gastric stapling procedures versus laparoscopic gastric banding. Am Surg 2014;80:1044-8.
Gero D, Favre L, Allemann P, et al. Laparoscopic Roux-En-Y Gastric Bypass Improves Lipid Profile and Decreases Cardiovascular Risk: a 5-Year Longitudinal Cohort Study of 1048 Patients. Obes Surg 2018;28:805-11.
Goff DC, Lloyd-Jones DM, Bennett G, et al 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Task Force on Practice Guidelines Circulation 2014;129:S49-73.
Gutierrez-Blanco D, Funes-Romero D, Madiraju S, et al. Reduction of Framingham BMI score after rapid weight loss in severely obese subjects undergoing sleeve gastrectomy: a single institution experience. Surg Endosc 2018;32:1248-54.
Hartz AJ, Rupley DC Jr, Kalkhoff RD, Rimm AA. Relationship of obesity to diabetes: influence of obesity level and body fat distribution. Prev Med. (1983) 12:351–7. doi: 10.1016/0091- 7435(83)90244-X
Heneghan HM, Meron-Eldar S, Brethauer SA, et al. Effect of bariatric surgery on cardiovascular risk profile. Am J Cardiol 2011;108:1499-507.
Kissebah AH, Vydelingum N, Murray R, et al. Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab 1982;54:254-60.
Lupoli R, Di Minno MN, Guidone C, et al. Effects of bariatric surgery on markers of subclinical atherosclerosis and endothelial function: a meta-analysis of literature studies. Int J Obes (Lond) 2016;40:395-402.
National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-421.
Nedeljkovic-Arsenovic O, Banovic M, Radenkovic D, et al. The Amount of Weight Loss Six Months after Bariatric Surgery: It Makes a Difference. Obes Facts 2019;12:281-90.
Piché MÈ, Martin J, Cianflone K, et al. Changes in predicted cardiovascular disease risk after biliopancreatic diversion surgery in severely obese patients. Metabolism 2014;63:79-86.
Priester T, Ault TG, Davidson L, et al. Coronary calcium scores 6 years after bariatric surgery. Obes Surg 2015;25:90-6.
Rimm EB, Stampfer MJ, Giovannucci E, Ascherio A, Spiegelman D, Colditz GA, Willett WC. Body size and fat distribution as predictors of coronary heart disease among middle-aged and older US men. Am J Epidemiol. (1995) 141:1117–27. doi: 10.1093/oxfordjournals.aje.a117385
Sjöström L, Peltonen M, Jacobson P, et al. Bariatric surgery and long-term cardiovascular events. JAMA 2012;307:56-65.
Stolberg CR, Mundbjerg LH, Funch-Jensen P, et al. Effects of gastric bypass surgery followed by supervised physical training on inflammation and endothelial function: A randomized controlled trial. Atherosclerosis 2018;273:37-44.
Torquati A, Wright K, Melvin W, et al. Effect of gastric bypass operation on Framingham and actual risk of cardiovascular events in class II to III obesity. J Am Coll Surg 2007;204:776-82.
Torres A, Rubio MA, Ramos-Leví AM, et al. Cardiovascular Risk Factors After Single Anastomosis Duodeno-Ileal Bypass with Sleeve Gastrectomy (SADI-S): A New Effective Therapeutic Approach? Curr Atheroscler Rep 2017;19:58.
Yayan J. Erythrocyte sedimentation rate as a marker for coronary heart disease. Vasc Health Risk Manag 2012;8:219-23.
